Lv21
120 积分 2024-10-01 加入
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections
4小时前
求助中
Identifying risk factors for methotrexate-induced acute kidney injury despite full prevention in patients with primary central nervous system lymphoma
17天前
已完结
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections
1个月前
已完结
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept
1个月前
已关闭
Insights into the population pharmacokinetics and pharmacodynamics of quetiapine: a systematic review
1个月前
已完结
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study
2个月前
已关闭
Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin
3个月前
已完结
Effect of body mass index on the timing of therapeutic drug monitoring—guided dalbavancin dosing in patients with osteoarticular infections
3个月前
已完结
Effect of body mass index on the timing of therapeutic drug monitoring—guided dalbavancin dosing in patients with osteoarticular infections
3个月前
已完结
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept
3个月前
已关闭
皖公网安备34019202002308
